Riskpilot← Back to searchSign inGet full accessPRELJEVIC AS
ASActiveOrg 918467793Dueveien 9, 2016 FrognerGeneral medical practice activities · NACE 8621Est. 20172 employees
Revenue 2024
NOK 6,1M
+6% vs 2023
EBITDA margin
44.2%
+40% vs 2023
Equity ratio
39.0%
Financial strength
Net profit 2024
NOK 1,7M
+21% vs 2023
| Revenue | NOK 6,1M | +6% |
| EBITDA | NOK 2,7M | +40% |
| Net profit | NOK 1,7M | +21% |
| Total assets | NOK 12,8M | +8% |
| Equity | NOK 5M | +51% |
| Employees | 2 | — |
Legal name
PRELJEVIC AS
Org number
918467793
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
28. januar 2017
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Lege og helsevirksomhet samt tjenester som kurs, undervisning med alt det innebærer, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapets virksomhet er og å investere i, eie, drifte og leie ut eiendom eid av eget selskap.
Address
Dueveien 9, 2016 Frogner
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2 163 | 1 328 | 1 805 | 2 596 | 2 868 | 5 380 | 5 718 | 6 058 |
| Staff expenses | −860 | −414 | −412 | −796 | −1 036 | −1 880 | −1 881 | −2 078 |
| EBITDA | 602 | 162 | 590 | 984 | 950 | 2 003 | 1 916 | 2 680 |
| Depreciation & amort. | −58 | −58 | −59 | −59 | −60 | −11 | −13 | −32 |
| EBIT | 543 | 103 | 532 | 925 | 890 | 1 992 | 1 904 | 2 647 |
| Net financials | 0 | −0 | −0 | −1 | −44 | −47 | −107 | −474 |
| Profit before tax | 543 | 103 | 531 | 924 | 846 | 1 945 | 1 797 | 2 173 |
| Tax | 130 | 28 | 122 | 210 | 192 | 429 | 396 | 478 |
| Net profit | 414 | 76 | 410 | 714 | 653 | 1 516 | 1 400 | 1 695 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 695 | 227 | 1 096 | 2 623 | 2 750 | 3 665 | 11 897 | 12 799 |
| Equity | 433 | 108 | 518 | 1 232 | 1 385 | 2 901 | 3 302 | 4 997 |
| Long-term debt | 0 | 0 | 0 | 1 050 | 997 | 0 | 7 861 | 6 995 |
| Short-term debt | 262 | 118 | 578 | 341 | 368 | 764 | 734 | 807 |
| Total debt | 262 | 118 | 578 | 1 391 | 1 365 | 764 | 8 595 | 7 802 |
EBITDA margin
44.2%
This company
15.8%
Market median
+180% vs market
20172024
Equity ratio
39.0%
This company
38.2%
Market median
+2% vs market
20172024
Return on equity
33.9%
This company
18.4%
Market median
+84% vs market
20172024
Net profit margin
28.0%
This company
8.1%
Market median
+246% vs market
20172024
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
20172024
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-10 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PRELJEVIC AS 
FROGNER MED ASBoard members of PRELJEVIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valjbona Preljevic | Chief Executive Officer | 0 companies |
| Rifat Preljevic | Chairman | 0 companies |